Ocasia logo

© Gulf Times

Noc News

Thailand wants to build sports medicine hospital similar to Qatar’s Aspetar

Date : 15 Mar 2019

Doha, Qatar, March 15, 2019: A high-level sporting delegation from Thailand was left highly impressed after visiting Aspetar, the orthopaedic and sports medicine hospital in Doha on Wednesday.

The Sports Authority of Thailand is looking at building a sports medicine hospital in the country and senior official Gongsak Yodmani commented that they would be looking at collaborating with Qatar to build a similar hospital in Thailand.

“In my opinion, Aspetar is one of the best sports medicine hospitals in the world. I have been to Japan, South Korea and Germany, I believe Aspetar has one of the most comprehensive offers out there. We are looking forward to cooperating with Qatar,” Yodmani, Governor of Sports Authority of Thailand, was quoted by the Gulf Times newspaper.

The senior delegation from Thailand included Mrs. Khunying Patama Leeswadtrakul, member of the International Olympic Committee and Executive Board member of the Thailand National Olympic Committee, Somsak Leeswadtrakul, President’s advisor of the Thailand National Olympic Committee, and Montri Chaipun, advisor to Yodmani and member of National Sports Training Centre.

The Thai delegation held extensive talks on ways in which Aspetar can support Thailand’s efforts to establish a sports medicine hospital based on Aspetar’s world-class model.

They were welcomed by Dr. Abdulaziz Jaham al-Kuwari, Aspetar acting Chief Executive Officer, who led the visitors on a tour of the hospital and briefed them on how the facility helped athletes.

The delegation also visited the new Aspire Academy Football Performance Centre and the Khalifa International Stadium.

Mrs. Khunying Patama Leeswadtrakul said: “We have seen the tremendous work in the area of sports development done here at Aspire and we intend to learn from Qatar and Aspire as well as exchange plans, programmes and know-how on youth sports development.”



Any personal data submitted will not be used for any direct marketing or unsolicited follow-up.